Interleukin Enhancer-binding Factor 3/NF110 Is a Target of YM155, a Suppressant of Survivin
Open Access
- 1 July 2012
- journal article
- Published by Elsevier BV in Molecular & Cellular Proteomics
- Vol. 11 (7)
- https://doi.org/10.1074/mcp.m111.013243
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Interleukin enhancer-binding factor 3 functions as a liver receptor homologue-1 co-activator in synergy with the nuclear receptor co-activators PRMT1 and PGC-1αBiochemical Journal, 2011
- Tankyrase inhibition stabilizes axin and antagonizes Wnt signallingNature, 2009
- Confirmation of Gene Expression–Based Prediction of Survival in Non–Small Cell Lung CancerClinical Cancer Research, 2008
- Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of SurvivinJournal of Clinical Oncology, 2008
- Nuclear Factor 45 (NF45) Is a Regulatory Subunit of Complexes with NF90/110 Involved in Mitotic ControlMolecular and Cellular Biology, 2008
- Identification of the cellular targets of bioactive small organic molecules using affinity reagentsChemical Society Reviews, 2008
- Splicing factor SF3b as a target of the antitumor natural product pladienolideNature Chemical Biology, 2007
- Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistanceBreast Cancer Research and Treatment, 2005
- RNA Binding and Phosphorylation Determine the Intracellular Distribution of Nuclear Factors 90 and 110Journal of Molecular Biology, 2005
- Crystal Structure of Human Survivin Reveals a Bow Tie?Shaped Dimer with Two Unusual ?-Helical ExtensionsMolecular Cell, 2000